A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review...

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Pharmacology

Background:

• Aging is a primary risk factor for atherosclerosis and associated ischemic events.
• Elderly patients with comorbidities are often excluded from clinical trials, creating knowledge gaps in treatment.
• Polypharmacy in older adults increases risks of drug interactions, toxicity, and non-adherence.

Purpose of the Study:

• To review existing evidence on managing extra-cardiac atherosclerotic occlusive disease in elderly patients.
• To identify gaps in evidence-based medicine for this population.
• To assess the effectiveness of lipid-lowering, antithrombotic, and glucose-lowering medications.

Main Methods:

• Searched public PubMed databases for relevant studies.
• Focused on evidence concerning elderly patients with extra-cardiac atherosclerotic lesions.
• Reviewed data on lipid-lowering, antithrombotic, and glucose-lowering therapies.

Main Results:

• Significant gaps exist in evidence-based management of extra-cardiac atherosclerosis in the elderly.
• Polypharmacy presents unique challenges in treating older patients with multiple comorbidities.
• Limited data specifically addresses the effectiveness of key medications in this demographic.

Conclusions:

• There is a critical need for more research on treating extra-cardiac atherosclerotic disease in older adults.
• Current treatment guidelines may not adequately address the complexities of aging and comorbidities.
• Further evidence is required to optimize pharmacotherapy and improve outcomes for elderly patients.